Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2016

May 10, 2016

32227_dirs_2016-05-10_8fca69ae-0ef9-41dc-8fe1-e1c936991db1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2016-05-09

Reporting Person: Robison William J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-05-09 Common Stock M 3333 $4.78 Acquired 177196 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2016-05-09 Stock Option (Right to buy) $4.78 X 3333 Disposed 2020-05-06 Common Stock (3333) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 173863 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $4.78 2020-05-06 Common Stock (10000) 6667 Direct

Footnotes

F1: On May 6, 2015 Mr. Robison was granted 10,000 stock options. The options vest ratably over the first three anniversary dates of the grant date. On May 9, 2016, Mr. Robison exercised 3,333 of these options leaving a balance of 6,667 stock options.